Stay updated on NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Sign up to get notified when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.

Latest updates to the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page
- Check2 days agoChange DetectedNo additions or deletions were observed; the page content remains unchanged.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check31 days agoChange DetectedPage updated to v3.1.0; removed the Ovarian cancer resource and old v3.0.2 reference.SummaryDifference0.2%

- Check45 days agoChange DetectedMajor update: the study now lists 22 locations with Plérin, France added, and it is updated to revision v3.0.2 with an estimated 2025 last-update label; older 2024 data (21 locations, v3.0.1) has been removed.SummaryDifference0.7%

- Check52 days agoChange DetectedThe page has updated the citation for a clinical research article, changing the publication date from May 16, 2025, to August 1, 2025, and correcting the spelling of 'unraveling' from British to American English. Additionally, the revision number has been updated from v3.0.0 to v3.0.1.SummaryDifference0.9%

- Check60 days agoChange DetectedThe web page has added a facility name and location details, including a specific address in Créteil, France, and has introduced new publications related to ovarian cancer. However, it has removed several terms and drug information related to ovarian cancer treatments.SummaryDifference4%

Stay in the know with updates to NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Enter your email address, and we'll notify you when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.